Progenitor cell transplantation
Relevant BNF section: 9.1.6
Many leukaemias and solid cancers are now treated with high-dose chemotherapy, an approach made possible by techniques that bolster haematological recovery when bone marrow suppression occurs. The conventional way of reversing marrow suppression has been to give an autologous bone marrow transplant (cells aspirated from the patient's own marrow). A newer technique, progenitor cell transplantation, also known as stem cell transplantation, is replacing bone marrow transplantation in this setting. It uses progenitor cells (derived from the pluripotent stem cells) which give rise to mature blood cells. These cells are taken from the patient's peripheral circulation and re-infused after high-dose chemotherapy. Here we describe progenitor cell transplantation and discuss how it compares with bone marrow transplantation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
